CoChat

Glymphatic MRI in idiopathic normal pressure hydrocephalus

Open access

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

The glymphatic system has in previous studies been shown as fundamental to clearance of waste metabolites from the brain interstitial space, and is proposed to be instrumental in normal ageing and brain pathology such as Alzheimer's disease and brain trauma. Assessment of glymphatic function using magnetic resonance imaging with intrathecal contrast agent as a cerebrospinal fluid tracer has so far been limited to rodents. We aimed to image cerebrospinal fluid flow characteristics and glymphatic function in humans, and applied the methodology in a prospective study of 15 idiopathic normal pressure hydrocephalus patients (mean age 71.3 ± 8.1 years, three female and 12 male) and eight reference subjects (mean age 41.1 + 13.0 years, six female and two male) with suspected cerebrospinal fluid leakage (seven) and intracranial cyst (one). The imaging protocol included T1-weighted magnetic resonance imaging with equal sequence parameters before and at multiple time points through 24 h after intrathecal injection of the contrast agent gadobutrol at the lumbar level. All study subjects were kept in the supine position between examinations during the first day. Gadobutrol enhancement was measured at all imaging time points from regions of interest placed at predefined locations in brain parenchyma, the subarachnoid and intraventricular space, and inside the sagittal sinus. Parameters demonstrating gadobutrol enhancement and clearance in different locations were compared between idiopathic normal pressure hydrocephalus and reference subjects. A characteristic flow pattern in idiopathic normal hydrocephalus was ventricular reflux of gadobutrol from the subarachnoid space followed by transependymal gadobutrol migration. At the brain surfaces, gadobutrol propagated antegradely along large leptomeningeal arteries in all study subjects, and preceded glymphatic enhancement in adjacent brain tissue, indicating a pivotal role of intracranial pulsations for glymphatic function. In idiopathic normal pressure hydrocephalus, we found delayed enhancement (P < 0.05) and decreased clearance of gadobutrol (P < 0.05) at the Sylvian fissure. Parenchymal (glymphatic) enhancement peaked overnight in both study groups, possibly indicating a crucial role of sleep, and was larger in normal pressure hydrocephalus patients (P < 0.05 at inferior frontal gyrus). We interpret decreased gadobutrol clearance from the subarachnoid space, along with persisting enhancement in brain parenchyma, as signs of reduced glymphatic clearance in idiopathic normal hydrocephalus, and hypothesize that reduced glymphatic function is instrumental for dementia in this disease. The study shows promise for glymphatic magnetic resonance imaging as a method to assess human brain metabolic function and renders a potential for contrast enhanced brain extravascular space imaging.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awx191

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 CSF contrast enhancement at multiple time points. Reconstructed T1-weighted images in sagittal (top row), axial (middle row) and coronal (bottom row) planes from MRI at baseline (before contrast agent administration) and at four of the subsequent imaging time points demonstrating time-dependent contrast enhancement of subarachnoid and intraventricular spaces in iNPH patient (A) and reference subject (B). Reflux of gadobutrol to the lateral ventricles was a typical feature of iNPH. In B, retrodural contrast enhancement can be seen on sagittal images (top row) at time points 1 h, 3 h and 4.5 h as sign of a CSF leakage (reference Subject 5).
Figure 1 CSF contrast enhancement at multiple time points. Reconstructed T1-weighted images in sagittal (top row), axial (middle row) and coronal (bottom row) planes from MRI at baseline (before contrast agent administration) and at four of the subsequent imaging time points demonstrating time-dependent contrast enhancement of subarachnoid and intraventricular spaces in iNPH patient (A) and reference subject (B). Reflux of gadobutrol to the lateral ventricles was a typical feature of iNPH. In B, retrodural contrast enhancement can be seen on sagittal images (top row) at time points 1 h, 3 h and 4.5 h as sign of a CSF leakage (reference Subject 5).CC BY-NC · PubMed Central
Figure 2 Trend plots of CSF tracer (gadobutrol) enhancement depending on location. Gadobutrol enhancement was delayed in iNPH patients as compared to reference subjects in (A) foramen magnum, (B) nearby pons, (C) Sylvian fissure, and (D) precentral sulcus. On the other hand, enhancement was significantly stronger within CSF of (E) fourth ventricle, (F) third ventricle, and (G) lateral ventricles. Reference subjects: continuous lines; iNPH patients: dotted lines. Differences between groups at individual time points were determined by independent samples t-test (*P < 0.05, **P < 0.01, ***P < 0.001).
Figure 2 Trend plots of CSF tracer (gadobutrol) enhancement depending on location. Gadobutrol enhancement was delayed in iNPH patients as compared to reference subjects in (A) foramen magnum, (B) nearby pons, (C) Sylvian fissure, and (D) precentral sulcus. On the other hand, enhancement was significantly stronger within CSF of (E) fourth ventricle, (F) third ventricle, and (G) lateral ventricles. Reference subjects: continuous lines; iNPH patients: dotted lines. Differences between groups at individual time points were determined by independent samples t-test (*P < 0.05, **P < 0.01, ***P < 0.001).CC BY-NC · PubMed Central
Figure 3 Perivascular enhancement. Gadobutrol enhancement in sulci traversed by the major cerebral arteries (anterior, middle and posterior) was identified and categorized as present/absent for each time point. (A) MRI in axial plane 1 h after contrast agent administration shows gadobutrol distributed to the interhemispheric fissure, Sylvian fissure and ambient cistern (arrows), and reflux to the third ventricle (dotted arrow). (B) At later time points, even though contrast subsequently distributed more freely in the subarachnoid spaces, there was a clear tendency for enhancement in cerebral fissures traversed by the anterior, middle and posterior arteries in both iNPH and reference subjects. (C) Evidence of perivascular gadolinium enhancement was categorized as present/absent for each time point. The percentage of individuals in whom a perivascular contrast enhancement was visualized, is plotted for each time point, showing significant differences between reference subjects and iNPH cohorts (20–40 min: P = 0.049; 40–60 min: P = 0.01; Pearson chi-square test). The plot in C suggests delayed perivascular flow at the brain surface in iNPH patients.
Figure 3 Perivascular enhancement. Gadobutrol enhancement in sulci traversed by the major cerebral arteries (anterior, middle and posterior) was identified and categorized as present/absent for each time point. (A) MRI in axial plane 1 h after contrast agent administration shows gadobutrol distributed to the interhemispheric fissure, Sylvian fissure and ambient cistern (arrows), and reflux to the third ventricle (dotted arrow). (B) At later time points, even though contrast subsequently distributed more freely in the subarachnoid spaces, there was a clear tendency for enhancement in cerebral fissures traversed by the anterior, middle and posterior arteries in both iNPH and reference subjects. (C) Evidence of perivascular gadolinium enhancement was categorized as present/absent for each time point. The percentage of individuals in whom a perivascular contrast enhancement was visualized, is plotted for each time point, showing significant differences between reference subjects and iNPH cohorts (20–40 min: P = 0.049; 40–60 min: P = 0.01; Pearson chi-square test). The plot in C suggests delayed perivascular flow at the brain surface in iNPH patients.CC BY-NC · PubMed Central
Figure 4 Glymphatic enhancement. Trend plots of gadobutrol enhancement in parenchyma depending on location, including (A) pons, (B) thalamus, (C) periventricular frontal horn, (D) inferior frontal gyrus (IFG), and (E) precentral gyrus. The T1 signal (signal unit) was significantly lower in iNPH cases at various locations in pons, thalamus, periventricular frontal horn, and IFG. In iNPH cases, the change was significantly higher in periventricular frontal horn and IFG between last daytime exam and at 24 h (Supplementary Table 3), and remained at a higher level after 24 h, indicative of delayed clearance. Reference subjects (Ref): continuous lines; iNPH patients: dotted lines. Differences between groups at individual time points were determined by independent samples t-test (*P < 0.05, **P < 0.01, ***P < 0.001).
Figure 4 Glymphatic enhancement. Trend plots of gadobutrol enhancement in parenchyma depending on location, including (A) pons, (B) thalamus, (C) periventricular frontal horn, (D) inferior frontal gyrus (IFG), and (E) precentral gyrus. The T1 signal (signal unit) was significantly lower in iNPH cases at various locations in pons, thalamus, periventricular frontal horn, and IFG. In iNPH cases, the change was significantly higher in periventricular frontal horn and IFG between last daytime exam and at 24 h (Supplementary Table 3), and remained at a higher level after 24 h, indicative of delayed clearance. Reference subjects (Ref): continuous lines; iNPH patients: dotted lines. Differences between groups at individual time points were determined by independent samples t-test (*P < 0.05, **P < 0.01, ***P < 0.001).CC BY-NC · PubMed Central
Figure 5 Glymphatic enhancement as function of CSF enhancement. The association between maximum enhancement within the CSF spaces and nearby brain parenchyma was determined for different regions of interest. For all locations (A–E), there was a highly significant correlation between contrast agent availability within the CSF space and enhancement of gadobutrol within nearby parenchyma.
Figure 5 Glymphatic enhancement as function of CSF enhancement. The association between maximum enhancement within the CSF spaces and nearby brain parenchyma was determined for different regions of interest. For all locations (A–E), there was a highly significant correlation between contrast agent availability within the CSF space and enhancement of gadobutrol within nearby parenchyma.CC BY-NC · PubMed Central
Figure 6 Transependymal flow of MRI contrast agent. (A) Periventricular hyperintensity (PVH) was identified and graded into four grades from FLAIR images (right column). The maximum increase in signal unit within the periventricular brain parenchyma between pre-contrast MRI (left column) and 24 h post-contrast MRI (middle column) was related to the periventricular hyperintensity categories. Top row: Axial sections; bottom row: coronal sections. (B) ANOVA with Bonferroni corrected post hoc tests revealed that periventricular enhancement was significantly larger in periventricular lucency grades 2 and 3 than grade 0.
Figure 6 Transependymal flow of MRI contrast agent. (A) Periventricular hyperintensity (PVH) was identified and graded into four grades from FLAIR images (right column). The maximum increase in signal unit within the periventricular brain parenchyma between pre-contrast MRI (left column) and 24 h post-contrast MRI (middle column) was related to the periventricular hyperintensity categories. Top row: Axial sections; bottom row: coronal sections. (B) ANOVA with Bonferroni corrected post hoc tests revealed that periventricular enhancement was significantly larger in periventricular lucency grades 2 and 3 than grade 0.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

8 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Research works printed but not linked: 1

  1. Cheng, 2004, Gadobutrol. Molecular Imaging and Contrast Agent Database (MICAD)

Cited by

See all 771

Metadata

Authors
Ringstad, G., Vatnehol, S. A. S., & Eide, P. K.
Affiliations
Oslo University Hospital (NO)
Corresponding author
Eide, Per Kristian
Venue
Brain
Published
2017-08-18
Volume
140
Issue
10
Pages
2691-2705
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W2750130602
Cited by
722
References
53
Citations by year
2026: 101 · 2025: 89 · 2024: 97 · 2023: 89 · 2022: 87 · 2021: 87 · 2020: 69 · 2019: 51 · 2018: 48 · 2017: 3
FWCI
22.87
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Brain (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • NORA - Norwegian Open Research Archives (submittedVersion, cc-by-nc)
Funders
University of Pennsylvania
Topics
  • Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
  • Health Sciences › Medicine › Clinical Neurology › Neurosurgical Procedures and Complications
Keywords
idiopathic normal pressure hydrocephalus, glymphatic system, cerebrospinal fluid flow, gadobutrol, sleep, leptomeningeal arteries, cerebrospinal fluid leak, brain cysts, brain waste clearance
MeSH terms
Adult, Aged, Aged, 80 and over, Contrast Media, Female, Humans, Hydrocephalus, Normal Pressure, Image Processing, Computer-Assisted, Magnetic Resonance Imaging, Male, Middle Aged, Organometallic Compounds, Prospective Studies, Subarachnoid Space, Time Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glymphatic MRI in idiopathic normal pressure hydrocephalus. https://app.cochat.ai/papers/10.1093/brain/awx191
The paper
Ringstad, G., Vatnehol, S. A. S., & Eide, P. K. (2017). Glymphatic MRI in idiopathic normal pressure hydrocephalus. Brain. https://doi.org/10.1093/brain/awx191

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.